Changes of KRAS Exon 2 Codon 12/13 Mutation Status in Recurrent Colorectal Cancer

Ottó Dócs, Ferenc Fazakas, Nóra Lugosiné Horváth, L. Tóth, C. András, Z. Horváth, G. Méhes

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is a heterogeneous disease presenting with a wide spectrum of morphological and molecular characteristics sometimes even within the same patient. To understand the mechanisms of oscillations in the KRAS status we evaluated the collective of CRC patients tested using allele-specific PCR and Sanger-sequencing. Mutant KRAS allele was observed in 43.3 % of cases. Repeated analysis of KRAS status in recurrent tumors or metastases was performed in 18/665 cases and a total of 6 cases with different KRAS status was found. In three cases the histological pattern of the tumor was identical. In one patient different histology and molecular status was seen between the primary and the recurrent tumor samples. In two further cases localization, histological type and KRAS mutational status all supported the occurrence of synchron/metachron colorectal tumors. In conclusion, both the progression of the original disease but also multiple tumor formation may contribute to mutation status differences during the course of colorectal carcinoma.

Original languageEnglish
Pages (from-to)399-404
Number of pages6
JournalPathology and Oncology Research
Volume21
Issue number2
DOIs
Publication statusPublished - Sep 24 2014

Fingerprint

Codon
Colorectal Neoplasms
Exons
Mutation
Neoplasms
Alleles
Disease Progression
Histology
Neoplasm Metastasis
Polymerase Chain Reaction

Keywords

  • Colorectal carcinoma
  • Heterogeneity
  • KRAS
  • Multiple tumors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine

Cite this

Changes of KRAS Exon 2 Codon 12/13 Mutation Status in Recurrent Colorectal Cancer. / Dócs, Ottó; Fazakas, Ferenc; Horváth, Nóra Lugosiné; Tóth, L.; András, C.; Horváth, Z.; Méhes, G.

In: Pathology and Oncology Research, Vol. 21, No. 2, 24.09.2014, p. 399-404.

Research output: Contribution to journalArticle

@article{d6527105ffbf414baf6d50f8bf5cbdde,
title = "Changes of KRAS Exon 2 Codon 12/13 Mutation Status in Recurrent Colorectal Cancer",
abstract = "Colorectal cancer (CRC) is a heterogeneous disease presenting with a wide spectrum of morphological and molecular characteristics sometimes even within the same patient. To understand the mechanisms of oscillations in the KRAS status we evaluated the collective of CRC patients tested using allele-specific PCR and Sanger-sequencing. Mutant KRAS allele was observed in 43.3 {\%} of cases. Repeated analysis of KRAS status in recurrent tumors or metastases was performed in 18/665 cases and a total of 6 cases with different KRAS status was found. In three cases the histological pattern of the tumor was identical. In one patient different histology and molecular status was seen between the primary and the recurrent tumor samples. In two further cases localization, histological type and KRAS mutational status all supported the occurrence of synchron/metachron colorectal tumors. In conclusion, both the progression of the original disease but also multiple tumor formation may contribute to mutation status differences during the course of colorectal carcinoma.",
keywords = "Colorectal carcinoma, Heterogeneity, KRAS, Multiple tumors",
author = "Ott{\'o} D{\'o}cs and Ferenc Fazakas and Horv{\'a}th, {N{\'o}ra Lugosin{\'e}} and L. T{\'o}th and C. Andr{\'a}s and Z. Horv{\'a}th and G. M{\'e}hes",
year = "2014",
month = "9",
day = "24",
doi = "10.1007/s12253-014-9834-2",
language = "English",
volume = "21",
pages = "399--404",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Changes of KRAS Exon 2 Codon 12/13 Mutation Status in Recurrent Colorectal Cancer

AU - Dócs, Ottó

AU - Fazakas, Ferenc

AU - Horváth, Nóra Lugosiné

AU - Tóth, L.

AU - András, C.

AU - Horváth, Z.

AU - Méhes, G.

PY - 2014/9/24

Y1 - 2014/9/24

N2 - Colorectal cancer (CRC) is a heterogeneous disease presenting with a wide spectrum of morphological and molecular characteristics sometimes even within the same patient. To understand the mechanisms of oscillations in the KRAS status we evaluated the collective of CRC patients tested using allele-specific PCR and Sanger-sequencing. Mutant KRAS allele was observed in 43.3 % of cases. Repeated analysis of KRAS status in recurrent tumors or metastases was performed in 18/665 cases and a total of 6 cases with different KRAS status was found. In three cases the histological pattern of the tumor was identical. In one patient different histology and molecular status was seen between the primary and the recurrent tumor samples. In two further cases localization, histological type and KRAS mutational status all supported the occurrence of synchron/metachron colorectal tumors. In conclusion, both the progression of the original disease but also multiple tumor formation may contribute to mutation status differences during the course of colorectal carcinoma.

AB - Colorectal cancer (CRC) is a heterogeneous disease presenting with a wide spectrum of morphological and molecular characteristics sometimes even within the same patient. To understand the mechanisms of oscillations in the KRAS status we evaluated the collective of CRC patients tested using allele-specific PCR and Sanger-sequencing. Mutant KRAS allele was observed in 43.3 % of cases. Repeated analysis of KRAS status in recurrent tumors or metastases was performed in 18/665 cases and a total of 6 cases with different KRAS status was found. In three cases the histological pattern of the tumor was identical. In one patient different histology and molecular status was seen between the primary and the recurrent tumor samples. In two further cases localization, histological type and KRAS mutational status all supported the occurrence of synchron/metachron colorectal tumors. In conclusion, both the progression of the original disease but also multiple tumor formation may contribute to mutation status differences during the course of colorectal carcinoma.

KW - Colorectal carcinoma

KW - Heterogeneity

KW - KRAS

KW - Multiple tumors

UR - http://www.scopus.com/inward/record.url?scp=84938196728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938196728&partnerID=8YFLogxK

U2 - 10.1007/s12253-014-9834-2

DO - 10.1007/s12253-014-9834-2

M3 - Article

C2 - 25248721

AN - SCOPUS:84938196728

VL - 21

SP - 399

EP - 404

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 2

ER -